About Takahide Koda
Takahide Koda is a board member at Immunis.
Takahide Koda first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Takahide Koda in the role, so the role may have started earlier or lasted longer.
Immunis, Inc.
Board Member
2024 – 2026 · Irvine, CA
Develops investigational therapies for people with age-related muscle and metabolic diseases.
Key Colleagues at Startups
The people Takahide Koda works with at each company, as listed on that company's latest Form D.
Immunis, Inc. · Form D, Jun 15, 2026
